Cargando…
Therapeutic Potential of Cholera Toxin B Subunit for the Treatment of Inflammatory Diseases of the Mucosa
Cholera toxin B subunit (CTB) is a mucosal immunomodulatory protein that induces robust mucosal and systemic antibody responses. This well-known biological activity has been exploited in cholera prevention (as a component of Dukoral(®) vaccine) and vaccine development for decades. On the other hand,...
Autores principales: | Royal, Joshua M., Matoba, Nobuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744099/ https://www.ncbi.nlm.nih.gov/pubmed/29168738 http://dx.doi.org/10.3390/toxins9120379 |
Ejemplares similares
-
Cholera Toxin B: One Subunit with Many Pharmaceutical Applications
por: Baldauf, Keegan J., et al.
Publicado: (2015) -
Repeated Oral Administration of a KDEL-Tagged Recombinant Cholera Toxin B Subunit Effectively Mitigates DSS Colitis despite a Robust Immunogenic Response
por: Royal, Joshua M., et al.
Publicado: (2019) -
Spray-Dried Formulation of Epicertin, a Recombinant Cholera Toxin B Subunit Variant That Induces Mucosal Healing
por: Reeves, Micaela A., et al.
Publicado: (2021) -
N-Glycosylation of Cholera Toxin B Subunit: Serendipity for Novel Plant-Made Vaccines?
por: Matoba, Nobuyuki
Publicado: (2015) -
Characterization and utility of two monoclonal antibodies to cholera toxin B subunit
por: Verjan Garcia, Noel, et al.
Publicado: (2023)